The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...
Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.
Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export ...
Illumina lowered its adjusted profit outlook and cut spending cost for 2025 as the company grapples with Chinese ban on its ...
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...
Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...
Dozens of foreign CEOs will visit Beijing this month for a flagship development conference where some are expected to meet ...
Illumina lowered its annual financial forecast and says it plans to cut about $100 million in costs after China banned imports of its gene sequencers last week. The San Diego maker of gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results